Review and consensus on pharmacogenomic testing in psychiatry
2024

Review of Pharmacogenomic Testing in Psychiatry

Editorial

Author Information

Author(s): Faiz Mark, Ahmed Sanjida

Primary Institution: Personalized Prescribing Inc., Toronto, ON, Canada

Hypothesis

Can pharmacodynamic algorithms improve pharmacogenomic testing for antidepressants?

Conclusion

Pharmacodynamic algorithms could enhance the effectiveness of pharmacogenomic tests by providing a more comprehensive understanding of drug efficacy.

Supporting Evidence

  • Testing for CYP2D6 and CYP2C19 is important but not sufficient for determining drug efficacy.
  • Almost 90% of all ethnicities have normal or moderate metabolism of antidepressants.
  • Pharmacodynamics requires a polygenic analysis rather than a one-gene approach.

Takeaway

This study suggests that looking at many genes together can help doctors choose the right medicine for their patients better than just looking at one or two genes.

Limitations

Limited research exists on how polygenic pharmacodynamics influences antidepressants.

Digital Object Identifier (DOI)

10.1017/S0033291724002095

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication